MedTrace Logo

A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer

NCT06356623 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 476

Last updated 2024-04-10

No results posted yet for this study

Summary

PONV management has been recommended as a necessary part of enhanced recovery protocols during the perioperative period, and PONV risk assessment is, therefore, a necessary first step in determining the number of medications or strategies for prophylaxis and treatment by considering the number of modifiable and non-modifiable risk factors. However, the external validity of two commonly-used PONV prediction models for patients undergoing liver surgery is unsatisfied, and need to be updated for liver cancer populations to better inform personalized perioperative care regime and individualized decision-making in clinical practice.

Conditions

Interventions

OTHER

1

this is not an intervention study

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-05
Primary Completion
2024-08-05
Completion
2024-08-06

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06356623 on ClinicalTrials.gov